Long non-coding RNA long intergenic non-coding 00641 mediates cell progression with stimulating cisplatin-resistance in osteosarcoma cells via microRNA-320d/myeloid cell leukemia-1 axis

References

• Zhu KP, Ma XL, Zhang CL. Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1. Int J Biol Sci. 2018;14(3):321–330.
   PubMed Web of Science ®Google Scholar
• Liu K, Hou Y, Liu Y, et al. LncRNA SNHG15 contributes to proliferation, invasion and autophagy in osteosarcoma cells by sponging miR-141. J Biomed Sci. 2017;24(1):46.
   PubMed Web of Science ®Google Scholar
• Serra M, Hattinger CM. The pharmacogenomics of osteosarcoma. Pharmacogenomics J. 2017;17(1):11–20.
   PubMed Web of Science ®Google Scholar
• Wang H, Qin R, Guan A, et al. HOTAIR enhanced paclitaxel and doxorubicin resistance in gastric cancer cells partly through inhibiting miR-217 expression. J Cell Biochem. 2018;119(9):7226–7234.
   PubMed Web of Science ®Google Scholar
• Li Z, Liang Z, Wang Q. Overexpression of long non-coding RNA HOTTIP increases chemoresistance of osteosarcoma cell by activating the Wnt/b-catenin pathway. Am J Transl Res. 2016;8(5):2385–2393.
   PubMed Web of Science ®Google Scholar
• Liu C, Lin J. Long noncoding RNA -AZS1 acts as an oncogene in osteosarcoma by epigenetically activating KCNC4. Am J Transl Res. 2016;8(10):4095–4105.
   PubMed Web of Science ®Google Scholar
• Sun L, Sun P, Zhou Q, et al. Long noncoding RNA MALAT1 promotes uveal melanoma cell growth and invasion by silencing of miR-140. Am J Transl Res. 2016;8(10):3939–3946.
   PubMed Web of Science ®Google Scholar
• Hanwen Z, Shuya L, Lian T, et al. Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/β-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9). Bioengineered. 2021;12:162–171.
   PubMed Web of Science ®Google Scholar
• Weiying Z, Qiang W, Du H, et al. CRISPR/cas9-mediated overexpression of long non-coding RNA SRY-box transcription factor 21 antisense divergent transcript 1 regulates the proliferation of osteosarcoma by increasing the expression of mechanistic target of rapamycin kinase and Kruppel like factor 4. Bioengineered. 2021. DOI:10.1080/21655979.2021.1995106
   Web of Science ®Google Scholar
• Lei S, Zhigang Z, Yibo G, et al. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p. J Cell Biochem. 2019;120:9656–9666.
   PubMed Web of Science ®Google Scholar
• Xingxing S, Cong T, Hui Z, et al. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma. Biomed Pharmacother. 2020;128:110201.
   PubMed Web of Science ®Google Scholar
• Jianping Z, Shengming J, Wenjun X, et al. Long noncoding RNA LINC00641 promotes renal cell carcinoma progression via sponging microRNA-340-5p. Cancer Cell Int. 2021;21:210.
   PubMed Web of Science ®Google Scholar
• Zhijia L, Shizhe H, Zhihu L. LncRNA LINC00641 predicts prognosis and inhibits bladder cancer progression through miR-197-3p/KLF10/PTEN/PI3K/AKT cascade. Biochem Biophys Res Commun. 2018;503:1825–1829.
   PubMed Web of Science ®Google Scholar
• Yi L, Lily Z, Pei Z, et al. Long non-coding RNA LINC00641 suppresses non-small-cell lung cancer by sponging miR-424-5p to upregulate PLSCR4. Cancer Biomark. 2019;26:79–91.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu Z, YuL-J H. Long non-coding RNA LINC00641 promotes cell growth and migration through modulating miR-378a/ZBTB20 axis in acute myeloid leukemia. Eur Rev Med Pharmacol Sci. 2019;23:7498–7509.
   PubMed Web of Science ®Google Scholar
• Bao L, Li X. MicroRNA-32 targeting PTEN enhances M2 macrophage polarization in the glioma microenvironment and further promotes the progression of glioma. Mol Cell Biochem. 2019;460(1–2):67–79.
   PubMed Web of Science ®Google Scholar
• Donzelli S, Mori F, Biagioni F, et al. MicroRNAs: short non-coding players in cancer chemoresistance. Mol Cell Ther. 2014;2:16–27.
   PubMedGoogle Scholar
• Xin L, Yingjie L, Zhanye L, et al. Exosomal long non-coding RNA LINC00662 promotes non-small cell lung cancer progression by miR-320d/E2F1 axis. Aging. 2021;13:6010–6024.
   PubMedGoogle Scholar
• Xiaojie C, Shegan G, Zhiwei Z, et al. MicroRNA-320d regulates tumor growth and invasion by promoting FoxM1 and predicts poor outcome in gastric cardiac adenocarcinomax. Aging. 2020;10:80.
   Google Scholar
• Ivan D, Alexis D, You-Wen H. The anti-apoptotic Bcl-2 family member Mcl-1 promotes T lymphocyte survival at multiple stages. J Immunol. 2008;181:521–528.
   PubMed Web of Science ®Google Scholar
• Inoue S, Walewska R, Dyer MJS, et al. Downregulation of Mcl-1 potentiates HDACi-mediated apoptosis in leukemic cells. Leukemia. 2008;22:819–825.
   PubMed Web of Science ®Google Scholar
• Céline G, White E. BH3-only proteins in control: specificity regulates MCL-1 and BAK-mediated apoptosis. Genes Dev. 2005;19:1263–1268.
   PubMed Web of Science ®Google Scholar
• Ming L, Ma W. miR-26a reverses multidrug resistance in osteosarcoma by targeting MCL1. Front Cell Dev Biol. 2021;9:645381.
   PubMed Web of Science ®Google Scholar
• Jiankuo G, Dongmei D, Tianlun Z, et al. HOTAIR promotes cisplatin resistance of osteosarcoma cells by regulating cell proliferation, invasion, and apoptosis via miR-106a-5p/STAT3 axis. Cell Transplant. 2020;29:963689720948447.
   PubMed Web of Science ®Google Scholar
• Yali Y, Leiming W, Zijun L, et al. Long noncoding RNA CRNDE functions as a diagnostic and prognostic biomarker in osteosarcoma, as well as promotes its progression via inhibition of miR-335-3p. J Biochem Mol Toxicol. 2021;35:e22734.
   PubMed Web of Science ®Google Scholar
• Xinxin C, Chengyong Z, Xiao W. Long noncoding RNA DLEU1 aggravates osteosarcoma carcinogenesis via regulating the miR-671-5p/DDX5 axis. Artif Cells Nanomed Biotechnol. 2019;47:3322–3328.
   PubMed Web of Science ®Google Scholar
• Jiang L, Quan-Min W, Xiao-Qing W, et al. Long noncoding RNA miR210HG sponges miR-503 to facilitate osteosarcoma cell invasion and metastasis. DNA Cell Biol. 2017;36:1117–1125.
   PubMed Web of Science ®Google Scholar
• Yang G, Chengtao L, Xiaoling Z, et al. hsa_circ_0000006 induces tumorigenesis through miR-361-3p targeting immunoglobulin-like domains protein 1 (LRIG1) in osteosarcoma. Ann Transl Med. 2021;9:1242.
   PubMed Web of Science ®Google Scholar
• Wenpeng Z, Jiang G, Honglu L, et al. FAM83H-AS1/miR-485-5p/MEF2D axis facilitates proliferation, migration and invasion of hepatocellular carcinoma cells. BMC Cancer. 2021;21:1310.
   PubMed Web of Science ®Google Scholar
• Shen DW, Pouliot LM, Hall MD, et al. Cisplatin resistance: a cellular self-defense mechanism resulting from multiple epigenetic and genetic changes. Pharmacol Rev. 2012;64(3):706–721.
   PubMed Web of Science ®Google Scholar
• Shaloam D, Bernard Tchounwou P. Tchounwou Paul Bernard, Cisplatin in cancer therapy: molecular mechanisms of action. Eur J Pharmacol. 2014;740:364–378.
   PubMed Web of Science ®Google Scholar
• Cheng F-H, Zhao Z-S, Liu W-D. Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p. Eur Rev Med Pharmacol Sci. 2019;23(17):7256–7265.
   PubMed Web of Science ®Google Scholar
• Jin-Yan W, Yang Y, Yajun M, et al. Potential regulatory role of lncRNA-miRNA-mRNA axis in osteosarcoma. Biomed Pharmacother. 2020;121:109627.
   PubMed Web of Science ®Google Scholar
• Chong-Zhen Q, Qiao-Li L, Yan-Tao Y, et al. Downregulation of MicroRNA-320d predicts poor overall survival and promotes the growth and invasive abilities in glioma. Chem Biol Drug Des. 2017;89:806–814.
   PubMed Web of Science ®Google Scholar
• Toshihiro T, Yoichi K, Shin H, et al. MicroRNA-320 family is downregulated in colorectal adenoma and affects tumor proliferation by targeting CDK6. World J Gastrointest Oncol. 2016;8:532–542.
   PubMed Web of Science ®Google Scholar
• Peng Yan W, Xu Dong Z, Jiang Z, et al. Low expression of microRNA-146b-5p and microRNA-320d predicts poor outcome of large B-cell lymphoma treated with cyclophosphamide, doxorubicin, vincristine, and prednisone. Hum Pathol. 2014;45:1664–1673.
   PubMed Web of Science ®Google Scholar
• Cui L, Yinmin Z, Zhao W, et al. miR-153-3p regulates progression of ovarian carcinoma in vitro and in vivo by targeting MCL1 gene. J Cell Biochem. 2019;120:19147–19158.
   PubMed Web of Science ®Google Scholar